Celldex has a strong cash position with a runway of 13-14 quarters, bolstered by a $424 million secondary offering in March 2024. Learn more on CLDX stock here.

The closely watched chronic spontaneous urticaria (CSU, or hives) space chalked more early stage KIT inhibitor data as Third Harmonic Bio Inc. rolled out results from the phase I single and multiple ...

Its medical name is “urticaria.” Hives can be acute (temporary) or chronic (ongoing). The condition is typically characterized by itchy, welts on the skin. Xolair is used to treat chronic ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

What if the food you eat and the way you handle stress could make a real difference for your chronic spontaneous urticaria?

Bio, Inc. (NASDAQ:THRD), a clinical-stage biopharmaceutical company with a market capitalization of $209.5 million, today announced positive Phase 1 clinical trial results for its drug candidate ...

The second trial – in chronic spontaneous urticaria ... There was also a 15.86-point reduction in urticaria activity – itch and hives – with Dupixent versus 11.21 points for the control ...

Stress has a huge impact on the way our skin ages. Stress hormones speed up the ageing process, causing more fine lines and wrinkles.

Story Feb. 11 - Third Harmonic Bio: The biotech announced it will lay off half of its workforce as it prepares to take its chronic spontaneous urticaria ... 1 data drop in hives and is laying ...

If your legs or other parts of your body itch when exposed to cold temperatures, it could be a sign of a health condition - ...

Feb. 3, 2025 — A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time ...